In 1970 Emory University established EGL Genetics (EGL) as an academic, not-for-profit organization, with the mission of performing biochemical, cytogenetics, and molecular clinical genetic testing. Since its inception, EGL has served as the only comprehensive provider of clinical and laboratory genetic services in Georgia. In January 1991, EGL achieved its first major growth milestone by expanding its molecular laboratory to explore improving technologies and advancements in DNA testing.
The three laboratories continued to operate under the Emory Department of Pediatrics until 2002, when Stephen Warren, PhD, FACMG, incorporated EGL into the newly created Emory Department of Human Genetics, which he founded. The Department of Human Genetics (www.genetics.emory.edu), performs research, teaching, and clinical services for the School of Medicine, and is home to the National Down Syndrome Project. It also serves as one of only three national Fragile X research centers.
In 2004 EGL Genetics, including its biochemical, cytogenetics, and molecular laboratories, were fully integrated into one comprehensive laboratory and moved to its current location. The facility is a 13,000+ square foot, state-of-the-art, Biological Safety Level II Laboratory, located approximately a half mile from the main Emory University campus.